Bimix (papaverine recalls
The FDA has published 1 recall involving Bimix (papaverine since 2023. The latest was reported on 18 Jan 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 18 Jan 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why bimix (papaverine is recalled
Companies
By year
All bimix (papaverine recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | BiMix Injection (Papaverine HCl/Phentolamine Mesylate) recalled | Northern VA Compounders Pllc | Sterility | Nationwide |
Should you stop taking Bimix (papaverine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.